Ophthalmic Business News

Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release.

Merck has announced the acquisition of all outstanding shares of EyeBio, making it a wholly-owned subsidiary, according to a company press release.

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.

In a shocking display of “where ya been?” the Federal Trade Commission has “discovered” that pharmacy benefit managers drive up the cost of medications.

Catch up on Healio’s top stories on the latest FDA news in ophthalmology.

As their parents age, many of our physician clients have asked us about long-term care insurance.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Doug Faunce, PhD, reviews AbbVie’s ongoing efforts in the eye care field.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Charles Semba, MD, chief medical officer of Eluminex Biosciences, discusses a trispecific antibody for refractory diabetic macular edema.

In this episode, Laura Enyedi, MD, chats with guest Kathryn Colby, MD, PhD, about her schooling, career, mentorship, chairmanship and being a parent.

Genentech is set to reintroduce Susvimo for patients with wet age-related macular degeneration nearly 2 years after it voluntarily recalled the ocular implant, according to a press release.